Perbedaan Jobubu Jarum Minahasa Tbk dan Merck Tbk.: Jobubu Jarum Minahasa Tbk diperdagangkan di Rp81 (kapitalisasi pasar 324 M, volume 24 jam 5,1 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.740 (kapitalisasi pasar 1,68 T, volume 24 jam 22,8 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,2× kapitalisasi pasar Jobubu Jarum Minahasa Tbk, dan Jobubu Jarum Minahasa Tbk lebih aktif diperdagangkan (5,1 jt vs 22,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BEER | MERK | |
|---|---|---|
Kapitalisasi Pasar | 324 M | 1,68 T |
Volume | 5,1 jt | 22,8 rb |
Lot | 50,98 rb | 228 |
Perputaran | 402,52 jt | 82,9 jt |
Harga Rata-rata | 78,96 | 3.636,14 |
Nilai Transaksi | 402,52 jt | 82,9 jt |
Harga Ekuilibrium Indikatif | 81 | 3.520 |
Volume Ekuilibrium Indikatif | 250 | 60 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Jobubu Jarum Minahasa Tbk (the “Company”) was established based on Notarial Deed No. 19 of Theomaris Eddy Boham, S.H., M.H., dated July 25, 2018. The Company started its commercial operations since December 2018. The majority shareholder of the Company is PT Maju Minuman Minahasa and the Company's Ultimate Beneficiary Owner (UBO) is Nico Lieke.
Selengkapnya di halaman BEER →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →